Içli F - Search Results

1

The effect of two different doses of oral clodronate on pain in patients with bone metastases.

Arican A, Içli F, Akbulut H, Cakir M, Sencan O, Samur M, Açikgöz N, Demirkazik A. Arican A, et al. Among authors: icli f. Med Oncol. 1999 Sep;16(3):204-10. doi: 10.1007/BF02906133. Med Oncol. 1999. PMID: 10523801 Clinical Trial.

2

Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP.

Dincol D, Buyukcelik A, Dogan M, Akbulut H, Samur M, Demirkazik A, Senler FC, Onur H, Icli F. Dincol D, et al. Among authors: icli f. Med Oncol. 2010 Sep;27(3):942-5. doi: 10.1007/s12032-009-9313-x. Epub 2009 Sep 29. Med Oncol. 2010. PMID: 19787462 Clinical Trial.

3

Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil.

Içli F, Arican A, Cay F, Akbulut H, Dinçol D, Karaoğuz H, Demirkazik A. Içli F, et al. Oncology. 1999;56(4):297-300. doi: 10.1159/000011981. Oncology. 1999. PMID: 10343193 Clinical Trial.

4

Overdosage of pamidronate in a patient with renal cell carcinoma.

Akbulut H, Icli F. Akbulut H, et al. Among authors: icli f. Med Oncol. 2000 Nov;17(4):340-1. doi: 10.1007/BF02782202. Med Oncol. 2000. PMID: 11114716 No abstract available.

5

Activity of irinotecan, cisplatin and dacarbazine (CPD) combination in previously treated patients with advanced colorectal carcinoma.

Akbulut H, Icli F, Yalcin B, Demirkazik A, Onur H, Buyukcelik A, Utkan G. Akbulut H, et al. Among authors: icli f. Exp Oncol. 2004 Jun;26(2):149-52. Exp Oncol. 2004. PMID: 15273666

6

High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas.

Yalcin B, Pamir A, Buyukcelik A, Utkan G, Akbulut H, Demirkazik A, Icli F. Yalcin B, et al. Among authors: icli f. Exp Oncol. 2004 Dec;26(4):320-5. Exp Oncol. 2004. PMID: 15627067 Clinical Trial.

7

Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer.

Icli F, Akbulut H, Utkan G, Yalcin B, Dincol D, Isikdogan A, Demirkazik A, Onur H, Cay F, Büyükcelik A. Icli F, et al. J Surg Oncol. 2007 May 1;95(6):507-12. doi: 10.1002/jso.20728. J Surg Oncol. 2007. PMID: 17192920 Clinical Trial.

8

Mesna/ifosfamide, mitoxantrone, etoposide, bleomycin, vincristine, prednisone (MINE-BOP) combination chemotherapy in the treatment of refractory and relapsed non-Hodgkin's lymphoma.

Dinçol D, Içli F, Karaoğuz H, Cay F, Arican A, Demirkazik A, Akbulut H. Dinçol D, et al. Among authors: icli f. Acta Oncol. 1995;34(7):937-40. doi: 10.3109/02841869509127208. Acta Oncol. 1995. PMID: 7492384

9

Two dose levels of ifosfamide in malignant mesothelioma.

Içli F, Karaoğuz H, Hastürk S, Kurt B, Akbulut H, Dinçol D, Demirkazik A, Cay F, Akyar S. Içli F, et al. Lung Cancer. 1996 Sep;15(2):207-13. doi: 10.1016/0169-5002(96)00584-3. Lung Cancer. 1996. PMID: 8882987 Clinical Trial.

10

Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer.

Içli F, Karaoguz H, Akbulut H, Dinçol D, Demirkazik A, Cay F. Içli F, et al. J Surg Oncol. 1997 Apr;64(4):318-23. doi: 10.1002/(sici)1096-9098(199704)64:4<318::aid-jso13>3.0.co;2-z. J Surg Oncol. 1997. PMID: 9142190 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters